Anita Rajasekhar

Hemophilia Treatment Centers (SPRANS)

Public Health Surveillance for the Prevention of Complications of Bleeding Disorders

Hemophilia Treatment Centers (SPRANS)

Community Counts Public Health Surveillance for the Prevention of Complications of Bleeding Disorders (FY24-25)

Public Health Surveillance for the Prevention of Complications of Bleeding Disorders

Public Health Surveillance for the Prevention of Complications of Bleeding Disorders

Hemophilia Treatment Centers (SPRANS)

University of Florida Hemphilia Treatment Center (HTC)

CTOA

Public Health Surveillance for the Prevention of Complications of Bleeding Disorders

Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase III Study with a Long-Term, Open-label Extension to Evaluate the Efficacy and Safety of TRM-201 (Rofecoxib) in Patients with Hemophilic Arthropathy

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of TAK-079 in Patients With Persistent/Chronic Primary Immune Thrombocytopenia

Southeast Region Comprehensive and Diagnostic Bleeding Treatment Center Program.

Efficacy and Safety of M281 in Adults with Warm Autoimmune Hemolytic Anemia: A Multicenter, Randomized, Double-blind, Placebo-controlled Study with a Long-term Open-label Extension

Public Health Surveillance for the Prevention of Complications of Bleeding Disorders

Advisory Services Agreement for development of a modified cTTP publication entitled “Treatment of Congenital Thrombotic Thrombocytopenia Purpura: A New Paradigm

A Multicenter, Post-Marketing Registry Study of COAGADEX in the Peri-operative Management of Patients with Moderate or Severe Hereditary Factor X Deficiency Undergoing Major surgery

Hemophilia Treatment Centers (SPRANS) Southeast Region Maternal and Child Health Bureau (MCHB) Bleeding Disorders Program

Prospective and retrospective, non-interventional study to evaluate the safety and effectiveness of Obizur in real-life practice

Public Health Surveillance for the Prevention of Complications of Bleeding and Clotting Disorders

Quality of care for inferior vena cava filters at UF Health Shands Hospital

Southeast Region Comprehensive and Diagnostic Bleeding Treatment Center Program.

Phase III, open-label, single-dose, multi-center multinational trial investigating a serotype 5 adeno- associated viral vector containing the Padua variant of a codon-optimized human factor IX gene (AAV5-hFIXco- Padua, AMT-061) administered to adult subjects with severe or moderately severe hemophilia B

Public Health Surveillance for the Prevention of Complications of Bleeding Disorders Project.

ATLAS-A/B: A Phase 3 Study to Evaluate the Efficacy and Safety of Fitusiran in Patients With Hemophilia A or B, Without Inhibitory Antibodies to Factor VIII or IX